Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 227,827 | 231,701 | 111,510 | 132,764 | 148,380 |
| Receivables | 9,282 | 20,321 | 20,185 | 16,420 | 15,583 |
| Other current assets | 3,388 | 3,077 | 2,206 | 2,525 | 2,063 |
| TOTAL | $242,996 | $258,454 | $138,632 | $152,955 | $170,063 |
| Non-Current Assets | |||||
| PPE Net | 73 | 81 | 91 | 71 | 80 |
| Intangibles | 545 | 544 | 545 | 545 | 545 |
| Other Non-Current Assets | 15,854 | 15,793 | 15,588 | 15,744 | 15,899 |
| TOTAL | $16,472 | $16,418 | $16,224 | $16,360 | $16,524 |
| Total Assets | $259,468 | $274,872 | $154,856 | $169,315 | $186,587 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,910 | 8,002 | 9,364 | 8,064 | 10,044 |
| Accrued Expenses | 13,752 | 22,978 | 28,603 | 28,877 | 22,256 |
| Other current liabilities | 1,409 | 294 | 121 | 144 | 327 |
| TOTAL | $19,029 | $32,128 | $38,863 | $37,903 | $33,422 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,768 | 5,035 | 4,981 | 4,928 | 4,874 |
| TOTAL | $9,973 | $5,259 | $5,113 | $5,105 | $5,160 |
| Total Liabilities | $29,002 | $37,387 | $43,976 | $43,008 | $38,582 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,988 | 75,623 | 60,954 | 60,368 | 60,368 |
| Common Shares | 40,526 | 39,119 | 32,182 | 32,182 | 31,855 |
| Retained earnings | -333,097 | -322,442 | -306,653 | -288,739 | -263,716 |
| Other shareholders' equity | -4,150 | -5,050 | -4,192 | -4,340 | -4,204 |
| TOTAL | $230,466 | $237,485 | $110,880 | $126,307 | $148,005 |
| Total Liabilities And Equity | $259,468 | $274,872 | $154,856 | $169,315 | $186,587 |